Nov
DEC
Jan
19
2014
2015
2016
1 captures
19 Dec 15 - 19 Dec 15
Close
Help
Skip to main content
Access brought to you by:
LOCKSS
Login
Search for this keyword
Advanced Search
Main menu
HOME
BROWSE BY CONFERENCE
BROWSE BY DISCIPLINE
-- All Disciplines --
Anesthesiology
Cardiology & Cardiovascular Medicine
Dentistry
Dermatology
Endocrinology, Diabetes & Metabolism
Emergency Medicine & Critical Care
Hematology
Hepatology
Infectious Diseases
Nephrology
Neurology
Nutrition
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopaedics & Sports Medicine
Psychiatry & Psychology
Pulmonary & Respiratory Medicine
Radiology
Rheumatology
Veterinary Medicine
ABOUT
About Us
International Medical Advisory Board
Reprints
Librarian resources
Contact us
Help
Demyelinating Diseases
Baseline Features of Patients With RMS in Ocrelizumab Trials OPERA I and OPERA II
REFLEXION Trial
Delayed Treatment of First MS Event Increases Time to CDMS
Teriflunomide Associated With Reductions in Severe MS Relapses
Disease Activity in Year 1 Predicts Long-term Outcomes in Patients Taking Fingolimod
DECIDE
Daclizumab HYP Superior to IFN-β-1a for Brain Lesion Activity in RRMS
Results of DECIDE: DAC HYP Superior to IFN-β-1a for RRMS
Controversies in Multiple Sclerosis Therapy
HspB5 Improves MRI Lesions and Clinical Relapse in RRMS
PR—Fampridine Improves Mobility in Patients with MS
Improvement in UI with OnabotulinumtoxinA Maintained over 4 Years in Patients with MS
Pages
Next
1
2
3
4